What is TRIO Pharmaceuticals worth?
$17.0Mlast known valuation
TRIO Pharmaceuticals last raised $1.9M in its Seed Round (Nov 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for TRIO Pharmaceuticals
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2022 | Seed Round | $1.9M | ▮ | ▮ |
How TRIO Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For TRIO Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is TRIO Pharmaceuticals worth?
- TRIO Pharmaceuticals's last known valuation is $17.0M.
- How much has TRIO Pharmaceuticals raised?
- TRIO Pharmaceuticals has raised $8.5M in total funding across 1 recorded rounds.
- When did TRIO Pharmaceuticals last raise?
- TRIO Pharmaceuticals last raised in Nov 2022 (Seed Round), raising $1.9M.